全文获取类型
收费全文 | 2497篇 |
免费 | 172篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 50篇 |
妇产科学 | 24篇 |
基础医学 | 275篇 |
口腔科学 | 64篇 |
临床医学 | 250篇 |
内科学 | 764篇 |
皮肤病学 | 75篇 |
神经病学 | 209篇 |
特种医学 | 63篇 |
外科学 | 322篇 |
综合类 | 36篇 |
一般理论 | 1篇 |
预防医学 | 163篇 |
眼科学 | 56篇 |
药学 | 131篇 |
中国医学 | 15篇 |
肿瘤学 | 166篇 |
出版年
2023年 | 23篇 |
2021年 | 49篇 |
2020年 | 26篇 |
2019年 | 53篇 |
2018年 | 65篇 |
2017年 | 50篇 |
2016年 | 43篇 |
2015年 | 62篇 |
2014年 | 54篇 |
2013年 | 55篇 |
2012年 | 94篇 |
2011年 | 115篇 |
2010年 | 83篇 |
2009年 | 62篇 |
2008年 | 121篇 |
2007年 | 78篇 |
2006年 | 107篇 |
2005年 | 77篇 |
2004年 | 115篇 |
2003年 | 106篇 |
2002年 | 113篇 |
2001年 | 121篇 |
2000年 | 95篇 |
1999年 | 85篇 |
1998年 | 26篇 |
1997年 | 38篇 |
1996年 | 31篇 |
1995年 | 14篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 74篇 |
1991年 | 45篇 |
1990年 | 62篇 |
1989年 | 58篇 |
1988年 | 42篇 |
1987年 | 45篇 |
1986年 | 35篇 |
1985年 | 47篇 |
1984年 | 36篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1979年 | 17篇 |
1978年 | 16篇 |
1977年 | 18篇 |
1974年 | 19篇 |
1973年 | 24篇 |
1972年 | 15篇 |
1970年 | 17篇 |
1968年 | 12篇 |
1967年 | 12篇 |
排序方式: 共有2698条查询结果,搜索用时 193 毫秒
1.
Norio Itokawa Masanori Atsukawa Akihito Tsubota Noritomo Shimada Hidenori Toyoda Koichi Takaguchi Atsushi Hiraoka Tomonori Senoh Mai Koeda Yuji Yoshida Tomomi Okubo Taeang Arai Korenobu Hayama Ai Nakagawa-Iwashita Chisa Kondo Katsuhiko Iwakiri 《Internal medicine (Tokyo, Japan)》2021,60(4):507
Objective Pegylated-interferon monotherapy is the standard treatment for patients with chronic hepatitis B; however, the factors associated with its therapeutic effects remain unclear. Methods Patients with chronic hepatitis B were treated with pegylated interferon α-2a for 48 weeks. We evaluated the kinetics of hepatitis B surface antigen (HBsAg) during treatment and follow-up periods and the factors associated with an HBsAg response (defined as a change in HBsAg of ≥-1 log IU/mL from baseline). Results The study population comprised 50 patients. The median baseline levels of hepatitis B virus DNA and HBsAg were 5.00 and 3.40 log IU/mL. The median values of HBsAg reduction from baseline were -0.44 (n=48), -0.41 (n=40), and -0.68 (n=11) log IU/mL at the end of treatment and at 48 and 144 weeks post-treatment, respectively. The rates of HBsAg response were 24.0% and 22.5% at the end of treatment and at 48 weeks post-treatment, respectively. A multivariate analysis identified HBsAg <3.00 log IU/mL as an independent baseline factor contributing to the HBsAg response at the end of treatment and 48 weeks post-treatment (p=1.07×10-2 and 4.42×10-2, respectively). There were significant differences in the reduction of the HBsAg levels at 12 weeks of treatment and in the incidence of serum ALT increase during treatment between patients with and without an HBsAg response. Conclusion These findings suggest that the baseline HBsAg level, HBsAg kinetics at 12 weeks of treatment, and ALT increase during treatment are important factors contributing to the HBsAg response in pegylated interferon α-2a monotherapy for patients with chronic hepatitis B. 相似文献
2.
3.
4.
5.
6.
7.
Miu Okubo Risako Chiba Takeo Karakida Hajime Yamazaki Ryuji Yamamoto Saeko Kobayashi Takahiko Niwa Henry C. Margolis Takatoshi Nagano Yasuo Yamakoshi Kazuhiro Gomi 《Journal of oral biosciences / JAOB, Japanese Association for Oral Biology》2019,61(1):43-54
Objectives
To investigate potential functions of transforming growth factor-beta (TGF-β) isoforms in maturation-stage ameloblasts during amelogenesis.Methods
In vivo activation of TGF-β was characterized by using matrix metalloproteinase 20 null (Mmp20-/-) and wild-type (Mmp20+/+) mice. Using mHAT9d cells cultured in the presence of each TGF-β isoform, (1) cell proliferation was determined by MTS assay, (2) immunostaining with anti-cleaved caspase-3 monoclonal antibody was performed and apoptotic indices were measured, (3) gene expression was analyzed by RT-qPCR, and (4) the uptake of amelogenin into mHAT9d cells was directly observed using a fluorescence microscope.Results
TGF-β1 and TGF-β3 were present in the enamel matrix of developing teeth which were activated by MMP20 in vivo. A genetic study revealed that the three TGF-β isoforms upregulate kallikrein 4 (KLK4) mRNA levels but downregulate carbonic anhydrase II. Moreover, TGF-β1 and TGF-β2 significantly upregulated the mRNA level of amelotin, whereas TGF-β3 dramatically downregulated the mRNA levels of odontogenic ameloblast-associated protein (ODAM), family with sequence similarity 83 member H (FAM83H), and alkaline phosphatase (ALP). Immunostaining analysis showed that the apoptosis of mHAT9d cells is induced by three TGF-β isoforms, with TGF-β3 being most effective. Both TGF-β1 and TGF-β3 induced endocytosis of amelogenin.Conclusions
We propose that TGF-β is regulated in an isoform-specific manner to perform multiple biological functions such as gene expression related to the structure of basal lamina/ameloblasts, mineral ion transport, apoptosis, and endocytosis in maturation-stage ameloblasts. 相似文献8.
9.
10.
Chisato Inomata Kazunori Ikebe Ryosuke Kagawa Hitomi Okubo Satoshi Sasaki Tadashi Okada Hajime Takeshita Sayaka Tada Ken-ichi Matsuda Yuko Kurushima Masahiro Kitamura Shinya Murakami Yasuyuki Gondo Kei Kamide Yukie Masui Ryutaro Takahashi Yasumichi Arai Yoshinobu Maeda 《Journal of dentistry》2014